LAUREN VEAZEY: Open Payments
NPI 1871850420 · NORTH LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,082 in 123 payments from 21 companies in 2025. Trend: 2023 $561 · 2024 $828 · 2025 $2,082
Food & beverage: $2,082
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $361 |
| AstraZeneca Pharmaceuticals LP | 16 | $336 |
| Lilly USA, LLC | 15 | $229 |
| PFIZER INC. | 11 | $186 |
| Amgen Inc. | 15 | $175 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $142 |
| Sumitomo Pharma America, Inc. | 6 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $100 |
| Novo Nordisk Inc | 6 | $100 |
| Astellas Pharma US Inc | 4 | $78 |
Products named: QULIPTA, MOUNJARO, NURTEC ODT, JARDIANCE, XIFAXAN, OTEZLA, AIRSUPRA, FARXIGA.
Industry payments across AR — which companies pay providers there.
